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ABSTRACT 
 
Introduction: Early detection of post-operative anastomotic leak reduces morbidity and 
leads to better outcomes following a leak. C- reactive protein recently has been studied as 
a useful marker of anastomotic healing with consistently high negative predictive values 
as early as postoperative day 4 onwards. However, its use is currently limited by variation 
in known cut-off values, lack of adequate representation of laparoscopic procedures and 
paucity of prospective data. 
 
Aims and Objectives: This study aimed to establish clinically useful post-operative CRP 
cut off values to facilitate safe and early discharge after elective colorectal anastomotic 
surgery and assess the effect of laparoscopic approach on post-operative CRP values. 
 
Methods: Serum CRP levels in patients undergoing elective abdominal surgery with a 
primary anastomosis was measured preoperatively and on post-operative day 4 for a total 
of 113 patients. All patients were followed up for 15 days for development of an 
anastomotic leak. The CRP values obtained were analyzed by receiver operator curve 
analysis to assess the diagnostic accuracy of a day 4 CRP value as an early detector of 
anastomotic leak.  
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Results and analysis: Anastomotic leakage will be diagnosed as per standard treating 
unitprotocols. The cut-off value of day 4 CRP with highest area under the curve in the 
receiver operator curve analysis was calculated and found to be 166mg/L for both open 
and laparoscopic procedures. The value for open procedures alone was also 166mg/L. 
Laparoscopic cut off value was 203mg/L but was limited by the lesser number of leaks in 
the laparoscopic group. (4 out of 33 laparoscopic surgeries) Bivariate analyses carried out 
between the occurrence of leak occurrence and sex, type of disease, approach of surgery, 
type of surgical procedure, level of anastomosis, stapled vs handsewn, curative vs 
palliative were not significant as assessed by Chi square tests.  An elevated CRP on day 4 
above 166mg/L is a sensitive and specific marker for early detection of a colorectal 
anastomotic leak. 
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Aim and Objectives 
 
 
Aim:  
This study aims to assess the role of CRP in early detection of colorectal anastomotic leak. 
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Objectives:  
 
 
 
1. To establish clinically useful post-operative CRP cut off values to facilitate safe and early 
discharge after elective colorectal surgery 
2. To assess the effect of laparoscopic approach on post-operative CRP values. 
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Introduction 
Advancements in surgery have led to a point where the modern surgeon no longer 
looks upon a colorectal malignancy as an unsurmountable obstacle, fraught with 
morbidity and looming death, but as a challenge to be met, aided with arsenal that 
modern oncological surgery and chemo-radiation provides.  The bloody, radical field of 
Miles’ radical abdomino-perineal resections have given way to literal bloodless planes of 
surgery, and a colorectal cancer diagnosis is no longer a death sentence. Unfortunately, 
despite such rapid advances in surgery and the wonders of neo-adjuvant chemo-radiation, 
the specter of anastomotic leaks continues to cast a dark veil over even the best equipped 
facilities.  
An anastomotic leak causes significant morbidity, carries a risk of mortality, 
delays treatment, prolongs recovery(1) and places a significant monetary burden on the 
patient, especially in resource poor settings like India. Despite vast repertoire of options 
that the modern colorectal surgeon has at hand- from newer neo-adjuvant 
chemotherapeutic regimens, to advances in laparoscopic techniques and instrumentation, 
the anastomotic leak rates across several studies has never touched an absolute zero(2).  
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The usual features that raise suspicion of a leak such as fever, tachycardia and abdominal 
signs of peritonitis, or even raised white cell counts often manifest too late to be clinically 
useful.(3). The actual event might have occurred much earlier but these traditional 
clinical markers manifest overtly only by the 7th or 8th day post-surgery. In the current era 
of ERAS (enhanced recovery after surgery) protocols, patients may often be discharged 
by the 4th or 5th day after surgery, before manifesting any overt clinical signs and may 
appear well. These patients however present a few days later by which time the patient is 
already profoundly septic. Another confounder is the difficulty in differentiating subtle 
signs of early sepsis from the normal post-operative inflammatory stress response.  
Alves et al(4) have shown that a delay in diagnosis leads to an 18% mortality and poor 
outcomes.  In contrast, earlier detection and treatment of anastomotic leak by day 4 or 5 
minimizes morbidity and improves post-operative outcomes.(5) 
              Thus, a cost effective and easily available marker that could be detected early in the sub-
clinical stage before overt sepsis occurs would be greatly valued. Several biological inflammatory 
markers have been proposed that might serve this purpose, such as interleukin 6, TNF alpha and 
pro-calcitonin. Unfortunately, many of them are prohibitively expensive, technically complicated 
to measure or not routinely available. The holy grail of anastomotic leak detection would be a 
simple, widely available, bedside inexpensive test that would be highly sensitive and specific and 
be detectable early enough to make a difference in management.  One such marker, CRP - C 
Reactive Protein has shown great promise as both a cost effective, and reliable early marker of 
anastomotic leak. Several studies have proven the role of C- reactive protein as a useful marker of 
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anastomotic healing, with consistently high negative predictive values (>95%)(6–9),as early as 
post-operative day 4 onwards. Despite consistent data to back this, its use is currently limited by 
variation in known cut-off values, lack of adequate representation of laparoscopic procedures for 
calculating cutoff values and paucity of prospective data.  
This study aims to answer the question of what would be a clinically useful cut-off value in early 
detection of anastomotic leak in our population subset, with emphasis on detection early enough 
such that meaningful intervention to reduce morbidity could be initiated. The second question we 
sought to solve was to establish if different cut-off values were needed for minimally invasive vs 
open procedures, keeping in mind the differences in the stress response in these two surgical 
approaches. 
    
Literature review 
C reactive protein is a pentameric molecule of hepatocyte origin and belong to the pentraxin group 
of plasma proteins, which are calcium dependent ligand binders. It was initially described as a 
distinct plasma protein that was detected in the initial phases of an infective process in 1930 by 
Tillet and Francis further described in 1947 by McCarty and others(10). It derives its name from 
its ability to precipitate the C-polysaccharide of S.pneumoniae (11) and was one of the first acute 
phase reactants to be extensively studied.  It is a mediator of the body’s non specific acute phase 
response to an insult-whether inflammatory, infective, traumatic or neoplastic. Normal levels are 
usually below 1mg/L, with the 90th percentile being 3mg/L(12) 
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Molecular Structure The molecular structure is that of 5 identical polypeptide subunits , each of 
206 amino acids, called protomers - which are linked to each other to form an annular structure 
with cyclical symmetry. The 5 protomers function as a single whole and do not exhibit activity as 
separate entities. Each protomer has two layers called the lectin fold – the concave side or the 
ligand binding side has double beta loops with two calcium ions linked to it, and the convex side 
has one alpha sheet. (12) The structure of each protomer exhibits a flattened jelly roll topology. 
 
Ribbon diagram of CRP with the “jelly roll” protein structure (13) 
In the diagram above the pentameric structure of 5 protein folded subunits are seen with the 
calcium ions pair represented in green, and the phosphocholine moiety seen attached to the calcium 
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pair by the phosphate end, and the choline moiety links to the Glu 81 protein. The entire 
phosphocholine molecule is held in a shallow trough on the concave side of the CRP protein, and 
the convex side bears the receptor site for C1q, thus enabling complement activation. 
 
Ligand binding and complement activation 
 
CRP binds most avidly to phosphocholine residues, which are widely present in most eukaryotic 
cell membranes as a constituent, about 10% of bacteria also contain PC (phosphocholine). It is 
also a component of complex polysaccharides which is a baseline structure in plants, bacterial and 
eukaryotic cells. (14) CRP also binds to a number of other structurally similar ligands apart from 
PC, both autologous and extrinsic. Apoptotic cell debris, PC residues of damaged cell membranes, 
lipoproteins are some common autologous ligands targeted. It also attaches to structural 
components of invading bacteria, fungi or parasites, or other phosphocholine or phospholipid 
moieties. The ligand is held on the concave side and the convex side attaches and activates C1q, 
thus triggering off the classical complement pathway. C3 adheres to the flagged structure and c5-
9 membrane attack complex is formed and activated.  Factor H mediated activation of alternate 
complement pathway also occur via attachment to CRP molecules already linked to target ligands. 
Thus in many ways CRP behaves like an antibody, and possibly plays an important role in humoral 
immunity.   
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CRP from an evolutionary perspective 
 
Interestingly the CRP structure is phylogenetically highly conserved with similar acute phase 
proteins expressed across vertebrates; though minor structural variations may exist. The degree to 
which each of these homologous proteins behave with regard to ligand binding and activity as 
acute phase reactants vary significantly. However, only human CRP has been demonstrated to be 
a potent complement activator. Interestingly, there is no known mutational deficiency known or 
polymorphism described. All these present a strong argument that CRP has over the timescale of 
evolution played a significant role in innate immunity, thus justifying its selection for preservation.   
The end result of such antibody like activity leads to complement directed damage and 
phagocytosis of these ligands, and in the case of a foreign pathogen, assist in clearance. When the 
ligands are autologous, the resultant effects are proinflammatory. The role of CRP in 
cardiovascular disease and CRP mediated complement directed inflammation has been recently 
elucidated with a view towards even considering CRP as a potential therapeutic target in reducing 
morbidity and mortality risks post an acute myocardial infarction.(12) 
 
There may also be a role for CRP in the prevention of autoimmunity; in patients with SLE, CRP 
function is highly impaired. Despite intense inflammation or infection, they may manifest only a 
modest rise in CRP levels. There have been antibodies linked to CRP, however patients with low 
CRP levels in SLE did not always have anti-CRP antibodies. (15) Transcripton factor aberrations, 
in particular with NF-κB and c-FOS have been implicated in impaired CRP response in SLE. 
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Mouse models with induced autoimmune entities were found to improve with administration of 
CRP. (16)   In addition, studies on other pentraxins, such as on SAP knock out mice models showed 
antinuclear autoimmune behavior without any inciting factor.   Such preservation of structure and 
function and its wide conservation across the phylogenetic spectrum leads us to believe that CRP 
as a molecule was highly valued as a part of host defenses.  
 
CRP as an ideal marker of inflammation 
 
 The hepatic synthesis of CRP is upregulated by cytokines released at the site of inflammation and 
peak values are reached by 48 hours.  There is no variation in production depending on the health 
status or nutritional state, only hepatic failure impairs production. The production does not change 
based on diet, age, sex, race, timing of food intake and there is no diurnal variation in synthesis. 
The production is under IL- 6 transcriptionaltransctiptional control, and serum levels rise rapidly 
within 5 hours after an inciting stimulus. It remains an exceptionally stable serum analyte and 
lends itself to reliable and accurate measurement with immunoassay tests.  The production of CRP 
is driven only by the inciting event. Once the stimulus is removed or falls, the levels of circulating 
CRP drop immediately. The plasma half-life is 19 hours and renal clearance is around 4 hours 
derived from mouse models.  Therefore, the CRP value is determined only by the rate of 
production and the levels of circulating CRP reflect very closely the in vivo status of the inciting 
event.  The baseline levels of CRP tend to increase with age probably reflecting underlying 
undetected subclinical pathologies. Obesity is also linked with higher normal range values, 
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reflecting the adipocyte production of extra hepatic CRP.(17) Other inflammatory markers do not 
exhibit the sensitivity and rapid response to inflammation as CRP. Serum amyloid P protein, 
another member of the pentraxin family does exhibit similar rises but does not lend itself to easy 
estimation. IL-6 and other cytokines are not practical to measure routinely. 
 
CRP vs Procalcitonin in detecting sepsis 
 
 Procalcitonin has been recently touted as a marker which is exquisitely sensitive to bacterial 
infection, with Garcia–Granero and others comparing it to CRP in detection of anastomotic 
leak.(9) In fact the only known contender to CRO is procalcitonin, with similar or even higher 
sensitivity. In answer to the question as to why not use procalcitonin over CRP the following 
reasons hold good: One, comparative studies examining CRP vs Procalcitonin have not shown any 
significant diagnostic advantage between the two, (18,19), Secondly, CRP has a better response to 
antibiotic therapy and is more useful in monitoring response to treatment. Thirdly, procalcitonin 
is more than thrice as expensive to measure, at Rs. 1105 at our center (17.20$) vs CRP at Rs. 335 
(5.20, thus precluding it as a practical test. If any, it could be used in a confirmatory test in the 
presence of an elevated CRP.   
 
CRP kinetics in response to surgery 
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In patients post major surgery, tissue damage drives CRP synthesis and the levels of CRP rise to 
peak by day 2 to between 100 to 150mg/L. In patients who have an uncomplicated post-operative 
outcome, this value will start to rapidly decline after this initial peak. At the end of a week, the 
CRP levels are still in the range of 40-50 mg/L, still higher than the pre-operative values.  The rise 
in CRP values is dependent on the extent of tissue damage, and as expected, open surgery has been 
reported to have a higher level of CRP as against minimally invasive approaches from the same 
procedure. Hildebrandt et al compared inflammatory markers including CRP following 
laparoscopic and open colonic resections and reported a mean day 2 value of 79mg/L for 
laparoscopic resections vs 115 mg/L for open procedures.(20)  Welsch et al report a median peak 
value of 140mg/l as the normal response to rectal surgery(21) and suggest that values higher than 
this be viewed with a high degree of suspicion.  
 It is of note that in patients who will develop a leak, the changes in CRP post-surgery are 
much higher right from day 1. The day 2 peak is higher , and continues to rise or plateau at least.  
This extremely early change in values suggest that the processes that lead to anastomotic 
dehiscence are in place right from day 1, and not just at the time of clinical detection. Welsch (21) 
and Almeida (22) argue that ischemia at the suture line or early necrosis at the stapler line incite 
this inflammatory response that translates to a higher CRP peak. Garcia-Granero in a study in 2006 
looked at intramucosal pH as a major causative factor for anastomotic leak finding that an 
intramucosal pH of less than 7.28 had a 22 fold higher risk of leaking. This ischemia manifest 
right from day 1, probably from the time of surgery itself, reflecting itself in higher CRP values 
right from day 1 in patients who will develop an adverse outcome.  
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 Another argument is that patients with a higher post operative CRP are candidates more 
likely to develop a complication due to some inherent or innate deficiencies that lead them to 
behave differently. If this was true, then there should have been a significantly higher value in 
CRP measured preoperatively, and this is certainly not the case. Multiple studies have found no 
significant difference in measurement of CRP values preoperatively.  In fact, patients who initiate 
treatment for a leak early enough show a corresponding drop in CRP values on par with normal 
post-operative patients, albeit with slightly higher values. This is not to say that a case cannot be 
made for CRP as a prognosticating tool in neoplasia especially in colorectal cancer. A systematic 
review of literature by Pathak et al(23) described shorter overall and disease free survival in 
patients with higher preoperative CRP values. However, in all studies that looked at immediate 
post-operative outcomes, the preoperative CRP values were not significantly different between 
patients who leaked and those who did not. Thus while relatively higher CRP preoperative levels 
may be a reflection of overall cancer burden on the body, and hence poorer outcomes – the same 
cannot be said on its effect on surgery.  The described “higher” preoperative values in patients 
with poor long term outcomes is also only of the order mg/dl as against the post-operative rise in 
the order of mg/L. The maximum values corresponding to poor outcome being between 10 to 
14mg/dl, vs post-operative values in of 150 to more than 200mg/L. It might therefore be safe to 
say that CRP values in the immediate post-operative period is solely determined by the immediate 
intraoperative factors that cause an anastomotic leak and by the presence or absence of local sepsis.  
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This graph from Almeida et al(22) shows the trend of CRP values following an anastomotic leak 
and in patients who have an uneventful post operative course. 
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FIG 2 
EVOLUTION OF CRP VALUES DAILY IN PATIENTS WITH AND WITHOUT LEAK 
 
 
 
 
 
 
This figure shows the trend of serum WBC counts in patients with a colorectal anastomosis who 
have leaked and those who have had a normal post-operative period. It is evident that the rise in 
WBC counts occur much later than CRP, and manifest only by the 6th day. 
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FIG 3 EVOLUTION OF WBC COUNTS IN PATIENTS WITH AND WITHOUT LEAK 
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Failure of traditional methods of detecting anastomotic leaks 
 
 The traditional clinical approach to detecting anastomotic leaks is to look for abdominal 
pain or distension, fever, tachycardia and signs of peritonitis- which are the bedside 
indicators of a intrabdominal sepsis. These indicators often may not be manifest overtly 
initially. Secondly, findings such as tachycardia and abdominal pain may also be caused 
by several other factors such as dehydration or inadequate pain relief, and are not truly 
specific. Laboratory parameters such WBC counts also may or may not be elevated in the 
intial stages. Almeida et al had shown that WBC counts do not become significantly 
elevated till after post-operative day 6.  Cross sectional imaging – CT scan, though is 
more sensitive, but is significantly more expensive and has a radiation risk. While there is 
no replacement for clinical acumen and the bedside examination, an adjunct to guide 
diagnosis is invaluable, especially when signs and symptoms are non-specific.  
This combination of clinical examination coupled with a sensitive indicator of sepsis 
enables the clinician to quickly categorize a patient as high risk, and therefore to be k 
monitored, or low risk and planned for discharge soon. Can other markers like 
procalcitonin be used? Yes, but the cost of it is too prohibitive to be a routine marker for 
all patients.   
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Hurdles in the early diagnosis of anastomotic leak 
It has been established that earlier diagnosis of an infective complication translates to better 
outcomes and late diagnosis leads to not just prolonged hospital stay and costs, but is also 
associated with higher risks of recurrence and mortality.  Unfortunately, the traditional methods 
of detecting an anastomotic leak are simply put, too crude to pick a leak early enough to initiate 
meaningful interventions.  
 Most leaks are detectable clinically only by the 6th or 7th day at the earliest. Even though 
the process of anastomotic site dehiscence may have started as early as day 1 or 2, most patients 
do not manifest any overt clinical signs till about 6 to 7 days after surgery. With the advent of 
enhanced recovery after surgery protocols, many of these relatively asymptomatic patients might 
end up getting discharged too early from hospital care, and return home, when in fact they should 
be under even more watchful surveillance. In our experience, many such patients worsen at home 
till, laboring under the impression that their symptoms are just another facet of the post-operative 
normal period, only to progressively worsen – By the time their symptoms are severe enough that 
they seek care, they are often far from hospital care.  
 
Another significant chunk of time is spent in travelling back to the hospital and through the 
emergency system.  Patients admitted in the hospital for monitoring do not do significantly better 
either. Most patients may only report a subjective sense of feeling unwell.  
 Objectively, they may be afebrile with a normal pulse, having moved their bowels post 
operatively with normal bowel sounds. A few may manifest only mild sense of nausea or of feeling 
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“unwell” or abdomen “not having fully settled yet’, hardly robust indicators for the treating team 
to rush to theatre or for cross sectional imaging. Traditional markers of inflammation such as white 
cell counts are notoriously variable and do not show a significant rise till day 6, by which time the 
diagnosis is not in doubt anymore.  
 
 
 
CRP as a marker for infective complications 
 
In patients who develop an infective complication after surgery there is now a new 
inciting factor that drives CRP production. This subset of patients will continue to have a 
rising CRP value, proportional to the extent of infection and sepsis.  CRP by virtue is a 
non-specific marker of inflammation and will rise irrespective of the cause of infection 
post operatively whether the source is pulmonary, or a urinary tract or catheter related 
blood stream infections or an anastomotic leak. Several studies over the last decade have 
conclusively demonstrated the use of CRP as an adjunct in monitoring for infective 
complications.  
 As mentioned earlier, all patients post-surgery manifest a CRP rise, however only 
those with an infective complication will persist to have elevated levels beyond the day 2 
peak. The difference in CRP values between normal patients and those who develop a 
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leak become clearest as early as day 4.  While the day 2 value in both sets of patients are 
expected to be elevated, and therefore not useful to make a judgement call, Straatman et 
al(24) noted that even this day 2 value was statistically significant – 196mg/L in 
uncomplicated patients and between 221 and 282 mg/L with anastomotic site leak. 
(24)(24)  
Garcia- Granero(9) et al in a similar study also compared serial values of CRP 
measured daily – though the difference in mean values between these two sets of patients 
become significant right from day 2 onwards, (151.4 – normal, 206.8- leaks p value 0.01) 
the maximum significance and area under the curve was seen on day 5. A meta analysis 
by Singh et al also found post-operative day 3 to 5 to be ideal with similar pooled AUC 
for these 3 days.(6) Almeida et al also recommended a day 3 value of 140mg/l as having 
the maximum sensitivity and specificity, though they also documented statistically 
significant values as early as day 2. (22)  
 
Laparoscopy vs Open surgery 
One issue raised in defining cutoff values to identify anastomotic leak is whether the 
reduced inflammatory stress of a laparoscopic surgery has any bearing on the post 
operative CRP values and if the cutoff needs to be adjusted to take into account this 
factor. Only one large study looked into laparoscopic data(25)(25) and found day 2 
values quite similar for open procedures, with values reported as 142.0mg/l (81.0–192.0) 
for normal patients vs 192 mg/l (103.0–238.0) for leaks, and day 4 values 60.5 (30.0–
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109.0) for normal course vs 13 109.0 (71.0–156.0) for leaks. The day 2 values were very 
similar to the values Garcia  reported with 20% of their procedures being laparoscopic 
approaches. Similar values are reported by Welsch et al, suggesting that the stress of 
colorectal dissection and surgery irrespective of laparotomy or laparoscopy invariably 
translates to almost similar maximum day 2 values. Day 4 values are slightly lower 
,compared to Garcia 102.8  normal ; 171.8 leaks.  
The laparoscopic surgery series from Adamina et al reported a value on day 4 of 
120mg/l as having a specificity of 80% for an infective complication, which is lower than 
the usual value of around 140mg/l suggested by other workers based on open procedures. 
Available data as described is conflicting and not conclusive enough to make a decision 
in this regard. . There was thus a need to further evaluate if a day 4 cutoff value needed to 
be different for laparoscopic vs open procedures or a single value would suffice. 
Available data as described is not conflicting and not conclusive enough to make a 
decision in this regard. 
 
Variation in definition of anastomotic leak   
There is no accepted definition for an anastomotic leak, with various studies considering 
different definitions with regard to mode of diagnosis, extent of contamination, with 
several overlapping terms – contained leak, minor complication, controlled leak, suture 
line dehiscence, disruption, major leak, anastomotic site collection. Correspondingly the 
leak rate following colorectal surgery varies from 1 to 40 %(26) depending on the 
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definition being used.  We have followed the policy that is used in our institution to 
define anastomotic leak and have restricted the criteria to be as objective as possible to 
reduce inter-observer variability bias.  The definitions used are detailed in the 
methodology section of this document.  
Prior to the work done by Rahbari et al (27) in defining the grades of an 
anastomotic leak, the terminologies used were legion. Words like ‘major leak’, 
‘contained leak, ‘minor leak’ ‘controlled fistula’, ‘radiological leak’ were common and 
added to inter-observer difficulties in communicating the true extent and clinical 
significance of an anastomotic site event. Each of these words though intending to 
communicate a certain aspect of the event, did not contribute to clarity. There is also still 
no fixed comprehensive guideline as to what exactly constitutes an anastomotic event that 
can be called a ‘leak’ per se, though Rahbari et al does qualify any ‘communication’ 
between the gut lumen and the extra luminal space as a ‘leak’, as well as a pelvic abscess 
located near the anastomotic site to be indicative of a leak. This consensus definition is 
what was used in our study and will be alluded to in the methodology section. The 
grading of the same is also split into class A, B and C; Class A being a benign post 
operative period with detection only at the time of reversal when distal contrast imaging 
is performed before closure of a temporary stoma. There is no clinical intervention 
needed for this grade of leakage. Class B constitutes patients who are symptomatic but do 
not require surgery. Features of fever, occasional high output drains, failure to “fully 
settle” and raised counts and CRP levels are typical. Owing to their clinical 
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manifestations, they are often imaged with CTs which may pick up small intra-abdominal 
or pelvic collections.  IV antibiotics and prolonged stay are all that may affect their post-
operative periods. Grade C patients are those that are sick with features of SIRS and 
warrant a re-exploration for sepsis control and management of the leak. They present 
with overt signs of sepsis and require urgent re-explorations failing which rapid 
deterioration is the norm. This consensus document has to an extent shed some clarity on 
clinically usable definitions.   
While prior definitions required the usage of cross sectional imaging or presence 
of laboratory findings such as leukocytosis or leukopenia or a raised CRP /procalcitonin 
level, these new criteria do not implicitly demand routine imaging, nor do their authors 
recommend it. Additional tests if required can be done to corroborate the diagnosis. It is 
interesting to note that even in this consensus document, the phrase ‘defect of integrity’ at 
the anastomotic site can imply either gross dehiscence at re-exploration for a peritonitic 
patient, or detected in an asymptomatic patient at the time of stoma reversal (if diverted), 
and therefore a wide spectrum is covered.  This guideline was created primarily for rectal 
resections, but we feel the criteria can be applied to our all colonic anastomoses.  
 
 
Lacunae in available data from published literature and justification for current study  
 
Current data available is limited by three issues: 
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One,  there is a significant variation in reported cut-off values below which a leak occurrence is 
considered unlikely, with different studies quoting values ranging from 56 mg/L19  to 140mg/L9 
Two, many of the cut-off values proposed are based on retrospective data, with the possibility of 
selection bias.15 Several retrospective studies measured CRP values on different days and not 
consistently on the fourth post-operative day. The majority of studies also did not blind the treating 
team to the assay levels. There is very little data from India in this regard with only one study 
published that did not find a correlation with anastomotic leak and elevated CRP values. 
Three, there is a paucity of conclusive data on the effect of laparoscopic surgery vs. open surgery 
on post-operative CRP in patients who have an anastomotic leak18-19. Laparoscopic procedures 
were under-represented in most studies.15, 16 The proportion of laparoscopic aided anastomotic 
procedures at this institute is much higher than those included in studies from which previous cut 
off values were calculated. Cut-off values obtained from our hospital patient population might thus 
be different.    
 
Our study aimed to fill in these gaps as mentioned above, Our study aimed to fill 
in these gaps as mentioned above; we chose a prospective study design at a high volume 
center with a wide disease type spectrum, with an intention to arrive at a cut-off value 
that would be relevant to our center.  This value would be consistently measured on the 
fourth post-operative day, and thus provide uniform consistent data to derive cutoff 
values from. We would also attempt to derive different cutoffs for both laparoscopic and 
open procedures, and compare them for any significant difference.   
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Methodology 
 
Design center: We chose out center the point of study as it was a national tertiary referral 
center, seeing a wide spectrum of cases. We also had several decades of experience in 
colorectal surgery with a separate colorectal surgical department with specialist trained 
surgeons working primarily/only in colorectal surgery.  
This center also had more than 10,000 outpatients seen in colorectal surgical unit 
alone per year, with 16,115 outpatients seen in 2016-2017. On average at least one 
thousand patients were admitted annually, with 1,432 inpatients admitted over the last 
year of which 399 patients were for colorectal surgical procedures. We reported 108 
colectomies in 2016-17, 99 rectal resections, including TAMIS and beyond TME 
resections. Of the 99 rectal resections, we had 72 resections for adenocarcinoma alone. At 
least 60% of rectal resections were performed laparoscopically. We reported a leak rate 
of 5.4% for rectal work alone. Out colectomy leak rate was higher at 15.9%.  
 
Study design: We chose a prospective observational study design wherein patients would 
be recruited serially from a prospective surgical theatre posting list. The study design was 
evaluated and cleared by the institutional review board and also from the ethical 
committee.  
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We chose two objectives: To establish clinically useful post-operative CRP cut off values 
to facilitate safe and early discharge after elective colorectal surgery and secondly to 
assess the effect of laparoscopic approach on post-operative CRP values.  
 
Setting:  Hospital wards and laboratories of Christian Medical College Vellore. 
 
Participants: Patients above 18 years who are admitted for elective colorectal 
surgery with a primary intestinal anastomosis in Christian Medical College Vellore 
were eligible for this study. All patients were given an information booklet that explained 
in detail the study, the type of testing done on them and the implications of the research. 
The booklet also made it clear that the patient would not receive direct benefit from 
participation but would help further the cause of better diagnostic modalities. It was also 
made clear that participation was voluntary and participation could be withdrawn at any 
time, if the patient so wished.   
 
Funding: The entire procedure was free, and there was no cost transferred to the patient at 
any level. The test was funded by a separate fluid grant from the research wing of the 
institution dedicated to post-graduate research. The sources for this fund was internal and 
received no funding or support from any pharmacological company or instrumentation 
lab or provider of equipment. There was no conflict of interest with regards to funding 
received at any level.   
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Inclusion criteria: 
- All patients who were above the age of 18 
- All patient who consented for the procedure 
- Patients undergoing a large intestinal anastomosis 
 
This included colectomies: right and left hemicolectomies, sigmoid resections, anterior 
resections, hartmanns reversals, colostomy closures, ileo rectal anastomoses for procto 
and panproctocolectomies – in short if there was any colonic or rectal or anal 
anastomosis, it was included in the study.  
 
Exclusion criteria: 
1. Emergency surgery 
2. Active infection prior to surgery 
3. Re-exploration/ leak detected before 4th post operative day 
4. Acute or chronic liver failure 
5. SLE, dermatomyosits, scleroderma 
6. Inflammatory bowel disease 
7. Leukemia 
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Patients undergoing emergency procedures were often obstructed or septic and therefore 
were in a state where the acute inflammatory response would be elevated. CRP levels 
would be grossly elevated preoperatively and would be presumptively elevated, thus 
precluding practically useful measurements post operatively. All such patients who had 
come obstructed, or underwent an emergency colectomy were excluded from the study.  
Active infections such as a wound infection, pneumonia or UTIs were excluded as they 
would have raised preoperative level as described above. 
 
Among eligible patients, those who were detected to have a leak before the fourth 
day were excluded from this study. Similarly, those who needed a major interventional 
procedure such as re-exploration for any cause, including leak were excluded. We had 
one patient who needed to be taken up on the third post-operative day for probable intra-
abdominal bleeding and was excluded. The reason was that such a major intervention 
would skew the post-operative day 4 values.  
  Acute and chronic hepatic failure would imply a reduction in hepatic synthesis of 
CRP and were hence excluded. 
Those diagnosed preoperatively with SLE, dermatomyositis and scleroderma were noted 
to have a deficient or abnormally low response to an inflammatory response.  As 
described earlier, these patients manifest a reduced CRP response to inflammation for 
several reasons as elucidated earlier and were hence excluded.  
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Several patients with inflammatory bowel disease require surgical resections, but 
it was noted that Crohns and ulcerative colitis have varying responses with regard to 
CRP. In particular, Crohns disease would have associated elevated CRP levels correlating 
well with disease activity, while ulcerative colitis would present only a reduced response. 
As both disease processes influenced CRP levels, they were excluded from the study. 
Leukemic patients also manifested an impaired response to inflammation and were hence 
excluded.   
 
It will be noted that we chose to include tuberculosis. The reasons for this was that 
CRP had not been correlated as closely with tuberculosis as that of IBD, though there are 
studies that link CRP with disease activity. The second cause was that while Crohn’s and 
ulcerative colitis have waxing and waning courses, and are essentially systemic disease 
stemming from an intrinsic disorder, tuberculosis is an external pathogenic stimulus 
similar to any other infection and once treated should not impair CRP production or 
clearance in any way.  
  
Eligible patients were consecutively recruited from the unit prospective operation registry 
list. They were recruited either at presentation to the outpatient department or at 
admission.  
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Sample Size: 
 All consenting patients meeting criteria between 1st January 2016 and 31st June 2017 
were recruited. It was planned to recruit a total of 120 patients based on approximately 80 
eligible anastomoses per year, based on the previous year’s audit data A total of 120 
patients were recruited over a period of 18 months.   
Of the 120 patients 7 patients were excluded for various reasons; 3 patients did not have a 
post-operative CRP value. 2 patients were detected to have Crohn’s disease post-
operatively, 1 patient backed out from the study and 1 patient was re-explored on the 
third post-operative day. In total 113 patients were finally included in the study. 
 
Primary outcome measure: The area under the curve of ROC curve analysis for 
Post-operative day 4 CRP value in relation to anastomotic leak. 
 
Exposure to risk: All patients were exposed to the risk of an anastomosis and a 
subsequent possibility of an anastomotic leak 
 
Effect modifiers: CRP levels increase post operatively and peak on the second day 
following surgery. The rise in CRP levels may be lesser in patients undergoing a 
laparoscopic procedure. Any repeat major surgical intervention before the 4th day 
will affect the CRP day 4 value and such patients will have to be excluded. (For 
example, a patient who is re-explored on day 1 or day 2 for a mesenteric bleed) 
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Diagnostic criteria: Any one of the following : 
1. Luminal or feculent contents in drain or from wound site 
2. Radiological evidence of anastomotic leak: presence of air or fluid collection in the 
peri-anastomotic region or intra-abdominal/ pelvic collection or contrast leak from 
anastomotic site 
3. Evidence of anastomotic dehiscence on re-exploration 
 
Collection of samples All patients who met the eligibility criteria and consented for the 
study had two samples collected, the first was a preoperative sample and the second on 
the fourth post-operative day. The convention followed for post-operative day tally was 
that the day of surgery was counted as post-operative day one and so forth. The samples 
were collected from a peripheral vein using a standard issue 5 or 2 cc syringe using a 23-
gauge needle via peripheral poke. Patients who had a central venous catheter still had a 
peripherally poked sample to prevent the small possibility of dilution of the sample.  
The samples were collected either by the principal investigator or by the qualified 
hospital phlebotomist. 
The samples were collected immediately in BD Vacutainer® Plus plastic serum tube, red 
hemograd cover, (BD, Inc., United States.) The samples were transported immediately 
to the microbiology department at the same institution and processed at once. 
Sample processing: All CRP measurements were quantified by immunonephelometry 
(Siemens nephelometer, Siemens AG). The lower limit of the cutoff was 3.14 mg/L and 
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the upper limit 203 mg/L. From 2016, higher dilutions were used and values above 203 
mg/L were also derived till 400 mg/L.  The values were reported on the online clinical 
workstation simultaneously as soon as the report was available.  
 
Bias: At the start of the study it was decided to blind the treating team, and the values 
were not uploaded online. In practice there were a few instances where blinding was not 
feasible. The treating team followed existing unit and hospital policy in detection and 
management of anastomotic leak and did not consider CRP as part of their evaluation or 
assessment 
 
Follow up: There was a 15 day follow up at minimum for all patients, as documented by 
post-operative OPD visits and documentation of current clinical status as well as 
telephonic phone calls if follow up in OPD was not present/required.  
 
Data entry: Values thus obtained were entered into a data-form sheet prepared earlier and 
tabulated. The values including CRP, patient demographics and details as the type of 
surgery, approach, leak presence, management of leak and other perioperative details 
were recorded. The same was entered onto an Epidata Manger form via the Epidata entry 
client, (The EpiData Association, Odense M, Denmark).  
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 Quantitative variables Age, Duration of hospital stay, CRP value were the quantitative 
variables collected. Age was recorded from the patients online chart. Duration of hospital 
stay was retrieved from the hospital clinical information management system and CRP 
was a continuous variable measured via nephelometry.  
 
 
Statistical methods 
The output from data entry was generated and analysed by SPSS software, (SPSS, IBM) 
and with PSPP ( GNU- PSPP, open source).  
 The CRP values on day 4 were plotted as an ROC curve with relation to the occurrence 
of an anastomotic leak. The ROC curves were plotted for all surgeries with leaks as well 
as for laparoscopic procedures and open surgeries separately. The diagnostic accuracy of 
CRP was estimated by plotting this ROC curve. The cutoff value of CRP was estimated 
from the plotted ROC with optimal sensitivity and specificity for each class i.e, open, 
laparoscopic and combined.  
Descriptive statistics for demographic and clinical continuous variables were represented 
as mean and standard deviation. Frequencies and percentages were given for categorical 
factors. Association between independent continuous covariates with types of surgery 
were assessed using the Mann-Whitney U test.   
 
49 
 
Results 
 
Over a period of 18 months, a total of 120 patients were recruited – consenting patients 
who met the eligibility criteria. 
As mentioned, 7 patients were excluded after exclusion criteria was applied. 
A total of 113 patients were eventually eligible for analysis after this. 
Of the 113 patients who underwent a colonic/rectal/anal anastomosis. 3 patients did not 
have a day 4 CRP value. This might have been to laboratory error as the samples were 
processed separately/ or failure of collection of the same on day 4. One of these patients 
had the value collected on the 6th post-operative day and was hence excluded. There were 
2 patients who were diagnosed to have Crohn’s disease post operatively and were unfit 
for the same as per exclusion criteria. One patient developed abdominal pain and had a 
sudden drop of hemoglobin, and was posted for a re-exploration and was excluded from 
the study. There was one patient who had initially consented but refused to have the day 
4 value performed and was hence removed.  
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Algorithm of study flow 
 
Consenting patients posted 
for elective surgery with 
colonic/rectal/anal 
anastomosis 
Fulfilled 
inclusion 
criteria 
N=120 
Excluded from study n=7 
3 – No Day 4 value 
2 – Crohn’s disease 
1 – Backed out 
1 – Re-explored Day 3 
 
Pre-operative  
CRP measured 
 N = 120 
 
Post-
operative Day 
4 CRP 
measured 
15 day follow up: 
Leaks = 22 
Statistical 
analysis  
 
Yes 
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Descriptive data:  
All data was available accessible on the online hospital database. 
Missing data: Patients with missing data were excluded from the study (3 patients did not 
have a day 4 CRP level) 
Out of a total of 113 anastomoses, a total of 22 leaks were described as per the diagnostic 
criteria for leak as mentioned earlier.  The median age was 52 years and ranging from 19 
to 81 years. The mean duration of stay (all patients) was 14.37 days, with a standard 
deviation of 7.392 days.   
 
 
Leak, 22
No leak, 91
Leaks (N=113)
Leak No leak
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This included leaks from all patients – both laparoscopic and open.  
With regard to gender distribution, there were 43 females and 70 males who underwent 
surgery. 
Male , 70
Female, 43
Gender (n=113)
Male Female
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With regard to the distribution of disease type, the majority of resection and anastomosis 
occurred for malignancies:  
There were a total of 92 malignancies operated upon, 8 diseases of infective etiology. 
These were usually cases who had been mainly diverted previously for perianal sepsis, 
NEOPLASM 
MALIGNANT
81%
INFECTIVE
7%
TUBERCULOUS
4%
TRAUMA
4%
NEOPLASM 
BENIGN
2% OTHER
2%
Disease type N=113
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Other: included resection for Hirschprung’s disease
 
 
 
 
 
 
Thus the three most common procedures were anterior resections, which formed a third 
of procedures, while right hemicolectomies and stoma reversals were about 50% of 
procedures.  
 
ANTERIOR 
RESECTION
29%
RIGHT 
HEMICOLECTOMY
27%
STOMA REVERSAL
24%
LEFT 
HEMICOLECTOMY
3%
SIGMOID 
COLECTOMY
6%
HARTMANN 
REVERSAL
5%
PANPROCTOCOLE
CTOMY
4%
OTHER
2%
Surgery Type
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Though 60% of rectal resections were performed laparoscopically, in total including all 
patients and procedures, a third were laparoscopic procedures.  
 
 
LAPAROSCOPIC
29%
LAPAROTOMY
68%
LAP CONVERTED 
OPEN
3%
Surgical Approach
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Non leak complications were noted in 39.8 % of patients. Most were superficial wound 
infections. 
 
12.4 % of complications were superficial wound infections, pneumonias accounted for 
1.8 % and urinary tract infections were 2.7 %. Other major complications accounted for 
the bulk of non-leak complications. These included burst abdomens, intra- abdominal 
collections, pancreatitis, one case of aortic thrombus, omental gangrene and a pelvic 
collection. We did not treat the detected pelvic collections as an anastomotic leak as the 
criteria that we had chosen at the beginning of the study did not recognize a collection in 
the absence of overt radiological evidence as constituting a leak.  
The majority of patients were detected to have a setback during the course of the initial 
admission itself. Only 22.7 % of patients were discharged and readmitted moribund – that 
is 5 out of 22 patients who leaked.  
YES
40%
NO
60%
Non leak complications
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Of the leaks that were manifest, half were re-explored and a third managed 
conservatively. 
 
No leak
80%
Premature discharge
4.5
Continued stay
15%
Leak
Leak and discharge dates
No leak Premature discharge Continued stay
CONSERVATIVE
36%
PERCUTANEOUS 
DRAIN
9%
RE 
EXPLORATION
55%
Leak management
CONSERVATIVE PERCUTANEOUS DRAIN RE EXPLORATION
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Bivariate analyses carried out between the occurrence of leak occurrence and sex, type of 
disease, approach of surgery, type of surgical procedure, level of anastomosis, stapled vs 
handsewn, curative vs palliative were not significant as assessed by Chi square tests. 
However Day 4 CRP levels were associated with an increased duration of stay as 
measured via logistic regression with  a p value of 0.02, and was also associated with 
presence of non – leak complications as measured by a Mann Whitney U test which gave 
a p value of 0.01 
 
The mean value of day 4 CRP for laparoscopic patient was 108.94 mg/L with that for 
open procedures being 116.57mg/L.  
 
Plotting of optimal CRP cut off values: 
The cut off value for CRP was calculated by plotting an ROC curve, with sensitivity and 
1-specificity on the different axes. The optimal value with maximum sensitivity and 
specificity was calculated. 
The data was analysed by SPSS software,  SPSS, IBM. 
The area under the curve was 0.853 corresponding to a diagnostic accuracy of 85.3% for 
CRP in detecting patents with an anastomotic leak.  The CRP cutoff value of 166mg/L 
yielded the maximum sensitivity and specificity (81.81% and 82.42% respectively). 
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This cutoff value is derived from all patients, including laparoscopic and open 
procedures.  
 
ROC Curve 
Sample Size : 113 
Positive Group : 22   ( 0.195) 
Negative Group : 91   ( 0.805) 
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Area under the ROC curve (AUC) 
Area under the ROC curve (AUC) : 0.853   ( 0.768, 0.916) 
Standard Error : 0.043 
Z - Statistic : 8.16 
Prob > Z (P - Value) : <0.001 
 
Summary 
Youden index J : 0.642 
Cutoff : 166 
Sensitivity (%) : 81.818 
Specificity (%) : 82.418 
 
(See table 1 in annexure with plotted values )  
The ROC curves were plotted again separately to include only patients who had 
undergone a laparoscopic procedure 
The values were plotted similarly as above and the AUC and optimal cutoffs calculated. 
(seen table 2 in annexures) 
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ROC Curve for Laparoscopic patients only
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ROC Curve 
Sample Size : 33 
Positive Group : 4   ( 0.121) 
Negative Group : 29   ( 0.879) 
 
Area under the ROC curve (AUC) 
Area under the ROC curve (AUC) : 0.888   ( 0.809, 0.942) 
Standard Error : 0.104 
Z - Statistic : 3.726 
Prob > Z (P - Value) : 0 
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Youden index J : 0.716 
Cutoff : 203 
Sensitivity (%) : 75 
Specificity (%) : 96.552 
 
The AUC was 0.888 , with the ROC curve yielding a cut off value of 203 as most 
accurate for diagnosing a leak. At 203mg/l the derived sensitivity was 75% and 
specificity 96.52%.  It was to noted that there was only a smaller sample with regards to 
leaks in this subgroup: only 4 leaks out of a total of 33 laparoscopic procedures.   
An ROC curve and cutoff values were also plotted for patient who underwent open 
procedures alone, excluding laparoscopic procedures. 
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Case Summary Open Procedures only 
 
 Valid N (listwise) 
LEAK OCCURENCE Unweighted Weighted 
Positive 18 18.00 
Negative 62 62.00 
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Area Under the Curve (DAY 4 CRP) 
   Asymp. 95% Confidence Interval 
Area Std. Error Asymptotic Sig. Lower Bound Upper Bound 
.85 .05 .000 .77 .93 
 
 
When cutoffs were calculated for just open procedures as well, the cut off values was the 
same at 166mg/L, as that of combined lap and open data.  
 
Discussion:   
Implications: 
 The most important advantage of CRP is that it allows the treating clinician to make a 
diagnosis of anastomotic leakage much earlier than what current methods currently 
available allow. In this manner, an elevated Day 4 CRP value acts as an early detector of 
anastomotic leakage. 
Currently patients are suspected to have an anastomotic event based on either clinical 
features or abnormal values such as leukocytopenia or leukocytosis, or if there is frank 
evidence of peritonitis. Unfortunately, none of these are useful to detect an anastomotic 
leak early enough. The major morbidity of an anastomotic event is that delayed 
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presentation and delay in diagnosis, or often a misdiagnosis leads to catastrophic 
outcomes. 
Earlier detection would lead to  
a. Earlier cross sectional imaging 
b. Earlier initiation of antibiotics  
c. Faster decision on need to post for surgery  
d. Overall improved outcomes from prevention of overt sepsis 
CRP analysis and testing does nothing to prevent a leak, however it reduces the major 
morbidity and mortality associated with delayed detection of an anastomotic leak. 
Garcia et al, Almeida et al (9,22) and several others have all shown conclusively the 
failure of traditional methods including signs as tachycardia and tachypnea and 
abdominal symptoms and fever in picking up a leak early enough. CRP being a highly 
sensitive non-specific marker of inflammation manifests this rise early when the patient is 
still stable, meaning before critical sepsis has set in. It gives the treating clinician a head 
start in managing sepsis and prevents the morbidity and poor outcomes associated with 
late detection. 
Therefore, it can be argued that the role of CRP in anastomotic leak is in the advantage 
gained by early detection. Earlier detection is also garnered from procalcitonin levels, but 
the cost of each test of 1,000 Rs to 1500 Rs as against the cost of CRP which is a third of 
the same precludes it from being a routine investigation in resource poor settings. 
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CRP yields itself most importantly as an early detector of the inflammatory response at 
the cellular level and hence as an early detector of anastomotic leak. 
A post-operative day 4 CRP value offers 3  other advantages. 
1. An objective non biased independent measure of leak probability 
2. Increases the positive predictive value of cross sectional imaging when used as 
‘CRP first’ approach 
3. As a negative predictive value index to facilitate safe discharge. 
There is of course no doubt that the there exists no substitute for good clinical practice 
and acumen. The bulwarks of clinical assessment- Pain, fever, tachycardia and abdominal 
signs are by no means indispensable. A day 4 CRP level may be used to either  
 
 
a. Corroborate the presence of a clinically suspected anastomotic event 
or  
b. Facilitate decision making in the presence of equivocal clinical signs that do not 
predicate discharge.  
Our principal objective was two-fold- to calculate an optimal cut off ratio for 
predicting safe discharge, and secondly to assess the effect of laparoscopic data on 
this cut off value. With regards to the derivation of the cutoffs, the values that we 
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arrived at for open procedures was 166mg/L on day 4 of admission. This cutoff of 166 
mg/L was linked to a sensitivity and specificity of 81.81% and 82.42%. This 
correlated with the cutoff values derived by other workers (7,9,22)We found out cut 
off values to be higher than what was quoted by Almeida(22) 140mg/L, or (9) Garcia 
et al 135mg/L and Ortega et al (7) 125mg/L. Plotting the different cutoffs against their 
respective sensitivities and specificities, we noted that at a cut off value of 140mg/L 
sensitivity was 82% with specificity 75%. Increasing the cutoff values to 203mg/L 
yielded a specificity of 93% with an expected reduced sensitivity of 41%. The best 
cutoff value was in the range between 150 mg/l (0.82%, 81%) and 169mg/L (0.77% 
and 82%). 
 
 
 
Variable DAY4CRP 
DAY 4 CRP 
Classification variable LEAK 
LEAK OCCURENCE 
  
Sample size 113 
Positive group a 22 (19.47%) 
Negative group b 91 (80.53%) 
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a LEAK = 1 
b LEAK = 2 
 
 
 
 
 
 
 
 
 
 
 
 
  
Disease prevalence (%) 19.5 
Area under the ROC curve (AUC)  
Area under the ROC curve (AUC)  0.853 
Standard Error a 0.0432 
95% Confidence interval b 0.774 to 0.912 
z statistic 8.160 
Significance level P (Area=0.5) <0.0001 
 
 
 
 
Youden index 
Youden index J 0.6424 
Associated criterion >159 
Sensitivity 81.82 
Specificity 82.42 
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ROC curve – CRP in anastomotic leak 
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In real world practice, discharging a patient involves the issue of weighing the 
risks of readmission vs the costs of unnecessary stay. A test that would help 
guide clinicians in assessing the same is invaluable. Therefore, the CRP value 
functions as one such parameter which when clubbed with clinical findings helps 
to identify at risk patients.  
 
A CRP cutoff value at too high a level such as >200mg/L would identify only 
patients with leak and have a high specificity, but at the cost of increasing false 
negatives. A false negative in our case is a readmission with a higher chance of 
mortality and significant morbidity.  
 
Therefore, clinical acumen tips the favor towards keeping a high sensitivity at 
the cost of a few false positives.  However, in our data, the sensitivity values 
between 104 and 165 mg/L remained the same at 82%. Above this at 86% a cut 
off value of 102mg/L yielded sensitivity of 86% but a very poor specificity of 
56%.  
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Therefore, it was decided to hold to the 166 mg/L value as an 
appropriate level to decide continued admission. 
  At this level, the negative predictive value was 93.8%. Keeping a cut off of 
102mg/l had a negative predictive value of 94.4, which was not significantly 
greater than what was achieved at 166mg/l, that too at the cost of a poorer 
specificity.     
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Thus we feel that the primary role of measuring CRP lies 
in its excellent capacity to detect a leak early enough 
such that meaningful interventions can be instituted to 
ensure better outcomes. 
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POSSIBLE CONFOUNDING FACTORS 
Possible confounding factors 
One possible confounder we considered was the presence of a non-leak 
complication raising CRP values in the post-operative period. CRP by virtue is a 
non-specific acute phase reactant and can be elevated also in other causes of 
infection:  
Our data had plotted presence of complications and CRP values and our data 
did not suggest a correlation – of all complications (non-leak) only 4 patients had 
a value more than 166mg/L in the absence of the leak. Two of them had a deep 
surgical site infection with burst abdomen, the other had pancreatitis post 
operatively, and the other two had an abdominal infected collection detected on 
CT imaging.  
 
All other complications, including pneumonia, urinary tract infections, and 
wound site infections did not have an elevated value that was greater than the cut 
off value derived. 
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ROLE AS AN EARLY DETECTOR OF ANASTOMOTIC LEAKAGE 
 
The prime usefulness of CRP is in early detection of the leak.  The role CRP 
plays in colorectal surgery is to aid as an early warning sign to practicing 
clinicians to detect these events earlier. 
 
 The key to salvaging a patient – between him spending days in the ICU 
moribund with a significant mortality and morbidity risk is ameliorated if the 
detection process is sped up, so that treatment can start way before the patient is 
so overtly in sepsis that even heroic measures will not be of use. 
 
 CRP does not predict a leak, it is not a tool to evaluate the likelihood of a leak 
occurring in a patient, rather, it is a marker to detect the leak which has occurred 
in the subclinical stage. 
 
This is what we feel is the key role of CRP in colorectal surgical practice – early 
detection to reduce the morbidity of a leak 
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ROLE AS A TOOL FOR EARLY DISCHARGE 
The practical application of this cut off arrives when there is a diagnostic 
dilemma with regard to deciding discharge or to keep monitoring. 
 It has been clearly demonstrated that WBC counts and clinical parameters have 
not been useful in detecting an anastomotic event in the first 5 days following 
surgery(7). 
 
 Patient with overt manifestations of sepsis often do not require any laboratory 
evidence or radiological imaging to suspect an anastomotic event, a toxic patient 
with a frankly peritonitic abdomen with fever and tachycardia is almost a given 
diagnosis.  
 
On the other hand, a patient who has moved his bowels, is afebrile, but has some 
abdominal discomfort that has not fully settled, perhaps slightly elevated 
ileostomy outputs, - these are patients who might be concealing a leak which 
may manifest itself only after the 5th or 6th day.  
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CRP IN THE ERA OF ERAS PROTOCOLS 
 
In this era of fast track and enhanced recovery protocols, clinicians are 
sometimes pressed to justify keeping a patient with only subjective symptoms of 
disease, when often their clinical experience hints at a gut feeling that there is a 
potential for an anastomotic event. CRP values at day 4 will provide this 
objective data to enhance clinical decision making.  
 
We recommend that patients who have a day 4 value of more than 166mg/L 
should not be discharged but kept for monitoring and perhaps imaging if 
clinically indicated.  
 
THE CRP FIRST APPROACH 
The other question that arises is whether using a strict cut off would 
increase the number of cross sectional imaging performed in a quest to look for a 
cause of an increased leak.  This might suggest a volley of CT scans done in the 
presence of an elevated CRP, however is very useful as a pre-test predictor for 
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CT scanning – the so called ‘CRP first approach’. (28)   An elevated  CRP value 
may only serve to guide appropriate usage of CT scans and increase pre-test 
positivity.  
 
LAPAROSCOPIC DATA AND CUTOFFS DERIVED 
With regards to laparoscopic data, we were limited by a small number of leaks in 
this arm – only 4 leaks out of 33 procedures. All these patients except one had a 
value of day 4 CRP greater than 203. The cutoff value generated on the ROC 
curve was optimal at 203mg/l with a sensitivity of 75% and specificity 96.52%. 
The values generated here have to be interpreted with caution as the sample size 
for laparoscopic procedures with leaks are less.  
 
 
It would be difficult to imply based on just 4 patients out of 33 laparoscopic 
procedures that a cut off of 203mg/l would be most appropriate. It might have 
been possible that all patients may have had overt sepsis by day 4 and therefore 
had higher values.   
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We found a correlation only between day 4 CRP and post-operative 
complications presence, p value 0.01 as measured  with a Mann – Whitney U 
test.  
There was also a correlation noted between Day 4 CRP and length of stay with 
regression analysis – ANOVA showing significance- p 0.02.  
 
There was no significance between leakage and any of the other demographic 
data, or the other surgical characteristic such as approach, method of 
anastomosis, level or stapled VS hand sewn.  
This correlated well with known data on anastomoti99c leak characteristics. (29).  
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Limitations 
We had initially attempted to blind the treating team from the CRP values, but in several 
cases blinding was not adequate.  Another limitation was the lower number of leaks in the 
laparoscopic arm – only 4 out of 33 procedures. It was felt that a larger number might be 
needed to calculate an appropriate cut off in this sub group. A larger laparoscopic group 
might enable inclusion of a wider spectrum of presentations and stages of anastomotic 
leak and hence provide a more accurate picture.  
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Conclusion 
We advise that a day 4 CRP be performed for all patients following an elective colorectal 
surgical procedure.  
The role of CRP in colorectal surgery lies in its ability as an early detector of anastomotic 
leak, thus ensuring early intervention. This would reduce the morbidity and mortality 
associated with delayed detection. 
Based on our data, we recommend that otherwise well patients with a day 4 CRP value 
less than 166mg/L for both laparoscopic and open procedures can be safely discharged 
More data needs to be collected for laparoscopic surgeries to conclusively prove if a 
different cut off is warranted in this subset.  
An elevated CRP level on day 4 should prompt the clinician to look for sources of sepsis, 
most importantly an anastomotic leak and to consider imaging with CT scan. 
 
 
 
 
 
 
84 
 
 
References 
 
  1.  McArdle CS, McMillan DC, Hole DJ. Impact of anastomotic leakage on long-term survival 
of patients undergoing curative resection for colorectal cancer. Br J Surg. 2005 
Sep;92(9):1150–4.  
2.  McDermott FD, Heeney A, Kelly ME, Steele RJ, Carlson GL, Winter DC. Systematic 
review of preoperative, intraoperative and postoperative risk factors for colorectal 
anastomotic leaks. Br J Surg. 2015 Apr 1;102(5):462–79.  
3.  Nason GJ, Barry BD, Obinwa O, McMacken E, Rajaretnam NS, Neary PC. Early rise in C-
reactive protein is a marker for infective complications in laparoscopic colorectal surgery. 
Surg Laparosc Endosc Percutan Tech. 2014 Feb;24(1):57–61.  
4.  Alves A, Panis Y, Pocard M, Regimbeau JM, Valleur P. Management of anastomotic 
leakage after nondiverted large bowel resection. J Am Coll Surg. 1999 Dec;189(6):554–9.  
5.  Factors determining delay in relaparotomy for anastomotic leakage after colorectal resection. 
- PubMed - NCBI [Internet]. [cited 2017 Jul 22]. Available from: 
https://www.ncbi.nlm.nih.gov/pubmed/17659732 
6.  Singh PP, Zeng ISL, Srinivasa S, Lemanu DP, Connolly AB, Hill AG. Systematic review 
and meta-analysis of use of serum C-reactive protein levels to predict anastomotic leak after 
colorectal surgery. Br J Surg. 2014 Mar;101(4):339–46.  
7.  Ortega-Deballon P, Radais F, Facy O, d’Athis P, Masson D, Charles PE, et al. C-reactive 
protein is an early predictor of septic complications after elective colorectal surgery. World J 
Surg. 2010 Apr;34(4):808–14.  
8.  Reynolds IS, Boland MR, Reilly F, Deasy A, Majeed MH, Deasy J, et al. C-reactive protein 
as a predictor of anastomotic leak in the first week after anterior resection for rectal cancer. 
Colorectal Dis Off J Assoc Coloproctology G B Irel. 2017 Mar 8;  
9.  Garcia-Granero A, Frasson M, Flor-Lorente B, Blanco F, Puga R, Carratalá A, et al. 
Procalcitonin and C-Reactive Protein as Early Predictors of Anastomotic Leak in Colorectal 
Surgery: A Prospective Observational Study. Dis Colon Rectum. 2013 Apr;56(4):475–83.  
10.  McCarty M. The Occurrence During Acute Infections of a Protein Not Normally Present in 
the Blood. J Exp Med. 1947 May 1;85(5):491–8.  
11.  Acute phase proteins with special reference to C-reactive protein and related proteins 
(pentaxins) and serum amyloid A protein. - PubMed - NCBI [Internet]. [cited 2017 Jul 21]. 
Available from: https://www.ncbi.nlm.nih.gov/pubmed/6356809 
85 
 
12.  Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003 Jun 
15;111(12):1805–12.  
13.  Thompson D, Pepys MB, Wood SP. The physiological structure of human C-reactive protein 
and its complex with phosphocholine. Structure. 1999 Feb;7(2):169–77.  
14.  Phosphorylcholine: friend or foe of the immune system? - PubMed - NCBI [Internet]. [cited 
2017 Jul 28]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/10203703 
15.  Bell SA, Faust H, Schmid A, Meurer M. Autoantibodies to C-reactive protein (CRP) and 
other acute-phase proteins in systemic autoimmune diseases. Clin Exp Immunol. 1998 
Sep;113(3):327–32.  
16.  Rodriguez W, Mold C, Kataranovski M, Hutt J, Marnell LL, Du Clos TW. Reversal of 
ongoing proteinuria in autoimmune mice by treatment with C-reactive protein. Arthritis 
Rheum. 2005 Feb;52(2):642–50.  
17.  Wener MH, Daum PR, McQuillan GM. The influence of age, sex, and race on the upper 
reference limit of serum C-reactive protein concentration. J Rheumatol. 2000 
Oct;27(10):2351–9.  
18.  Oberhofer D, Juras J, Pavičić AM, Rančić Žurić I, Rumenjak V. Comparison of C-reactive 
protein and procalcitonin as predictors of postoperative infectious complications after 
elective colorectal surgery. Croat Med J. 2012 Dec;53(6):612–9.  
19.  Zawadzki M, Czarnecki R, Rzaca M, Obuszko Z, Velchuru VR, Witkiewicz W. C-reactive 
protein and procalcitonin predict anastomotic leaks following colorectal cancer resections – a 
prospective study. Videosurgery Miniinvasive Tech. 2015 Dec;10(4):567–73.  
20.  Hildebrandt U, Kessler K, Plusczyk T, Pistorius G, Vollmar B, Menger MD. Comparison of 
surgical stress between laparoscopic and open colonic resections. Surg Endosc. 2003 
Feb;17(2):242–6.  
21.  Welsch T, Müller SA, Ulrich A, Kischlat A, Hinz U, Kienle P, et al. C-reactive protein as 
early predictor for infectious postoperative complications in rectal surgery. Int J Colorectal 
Dis. 2007 Dec;22(12):1499–507.  
22.  Almeida AB, Faria G, Moreira H, Pinto-de-Sousa J, Correia-da-Silva P, Maia JC. Elevated 
serum C-reactive protein as a predictive factor for anastomotic leakage in colorectal surgery. 
Int J Surg Lond Engl. 2012;10(2):87–91.  
23.  Pathak S, Nunes QM, Daniels IR, Smart NJ. Is C-reactive protein useful in prognostication 
for colorectal cancer? A systematic review. Colorectal Dis. 2014 Oct 1;16(10):769–76.  
24.  Straatman J, Cuesta MA, Gisbertz SS, Van der Peet DL. Value of a step-up diagnosis plan: 
CRP and CT-scan to diagnose and manage postoperative complications after major 
abdominal surgery. Rev Espanola Enfermedades Dig Organo Of Soc Espanola Patol Dig. 
2014 Dec;106(8):515–21.  
86 
 
25.  Adamina M, Warschkow R, Näf F, Hummel B, Rduch T, Lange J, et al. Monitoring c-
reactive protein after laparoscopic colorectal surgery excludes infectious complications and 
allows for safe and early discharge. Surg Endosc. 2014 Oct;28(10):2939–48.  
26.  Bellows CF, Webber LS, Albo D, Awad S, Berger DH. Early predictors of anastomotic leaks 
after colectomy. Tech Coloproctology. 2009 Mar;13(1):41–7.  
27.  Rahbari NN, Weitz J, Hohenberger W, Heald RJ, Moran B, Ulrich A, et al. Definition and 
grading of anastomotic leakage following anterior resection of the rectum: a proposal by the 
International Study Group of Rectal Cancer. Surgery. 2010 Mar;147(3):339–51.  
28.  McSorley ST, Khor BY, MacKay GJ, Horgan PG, McMillan DC. Examination of a CRP 
first approach for the detection of postoperative complications in patients undergoing surgery 
for colorectal cancer. Medicine (Baltimore) [Internet]. 2017 Feb 17;96(7). Available from: 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319530/ 
29.  Park JS, Huh JW, Park YA, Cho YB, Yun SH, Kim HC, et al. Risk Factors of Anastomotic 
Leakage and Long-Term Survival After Colorectal Surgery. Medicine (Baltimore) [Internet]. 
2016 Mar 3;95(8). Available from: 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779025/ 
 
Annexure 
 
ROC curve 
Variable DAY4CRP 
DAY 4 CRP 
Classification variable LEAK 
LEAK OCCURENCE 
  
Sample size 113 
Positive group a 22 (19.47%) 
Negative group b 91 (80.53%) 
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a LEAK = 1 
b LEAK = 2 
  
Disease prevalence (%) 19.5 
Area under the ROC curve (AUC)  
Area under the ROC curve (AUC)  0.853 
Standard Error a 0.0432 
95% Confidence interval b 0.774 to 0.912 
z statistic 8.160 
Significance level P (Area=0.5) <0.0001 
a DeLong et al., 1988 
b Binomial exact 
Youden index 
Youden index J 0.6424 
Associated criterion >159 
Sensitivity 81.82 
Specificity 82.42 
Criterion values and coordinates of the ROC curve [Hide] 
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2.0
7 
1.6 - 
2.7 
0.1
6 
0.04 
- 0.6 
33.
3 
27.7 - 
39.5 
96.
2 
87.0 - 
99.0 
>101 86.36 65.1 - 
97.1 
56.04 45.2 - 
66.4 
1.9
6 
1.5 - 
2.6 
0.2
4 
0.08 
- 0.7 
32.
2 
26.3 - 
38.7 
94.
4 
85.4 - 
98.0 
>103 81.82 59.7 - 
94.8 
56.04 45.2 - 
66.4 
1.8
6 
1.4 - 
2.5 
0.3
2 
0.1 - 
0.8 
31.
0 
24.9 - 
37.9 
92.
7 
83.8 - 
96.9 
>105 81.82 59.7 - 
94.8 
57.14 46.3 - 
67.5 
1.9
1 
1.4 - 
2.6 
0.3
2 
0.1 - 
0.8 
31.
6 
25.3 - 
38.6 
92.
9 
84.0 - 
97.0 
>106 81.82 59.7 - 
94.8 
58.24 47.4 - 
68.5 
1.9
6 
1.4 - 
2.7 
0.3
1 
0.1 - 
0.8 
32.
1 
25.7 - 
39.3 
93.
0 
84.3 - 
97.0 
93 
 
>107 81.82 59.7 - 
94.8 
59.34 48.5 - 
69.5 
2.0
1 
1.5 - 
2.8 
0.3
1 
0.1 - 
0.8 
32.
7 
26.2 - 
40.0 
93.
1 
84.6 - 
97.1 
>108 81.82 59.7 - 
94.8 
60.44 49.6 - 
70.5 
2.0
7 
1.5 - 
2.9 
0.3
0 
0.1 - 
0.7 
33.
3 
26.6 - 
40.8 
93.
2 
84.8 - 
97.1 
>109 81.82 59.7 - 
94.8 
61.54 50.8 - 
71.6 
2.1
3 
1.5 - 
2.9 
0.3
0 
0.1 - 
0.7 
34.
0 
27.1 - 
41.6 
93.
3 
85.0 - 
97.2 
>112 81.82 59.7 - 
94.8 
62.64 51.9 - 
72.6 
2.1
9 
1.6 - 
3.0 
0.2
9 
0.1 - 
0.7 
34.
6 
27.5 - 
42.4 
93.
4 
85.3 - 
97.2 
>113 81.82 59.7 - 
94.8 
63.74 53.0 - 
73.6 
2.2
6 
1.6 - 
3.2 
0.2
9 
0.1 - 
0.7 
35.
3 
28.0 - 
43.3 
93.
5 
85.5 - 
97.3 
>114 81.82 59.7 - 
94.8 
65.93 55.3 - 
75.5 
2.4
0 
1.7 - 
3.4 
0.2
8 
0.1 - 
0.7 
36.
7 
29.1 - 
45.1 
93.
8 
85.9 - 
97.4 
>115 81.82 59.7 - 
94.8 
68.13 57.5 - 
77.5 
2.5
7 
1.8 - 
3.7 
0.2
7 
0.1 - 
0.7 
38.
3 
30.2 - 
47.1 
93.
9 
86.3 - 
97.4 
>120 81.82 59.7 - 
94.8 
69.23 58.7 - 
78.5 
2.6
6 
1.8 - 
3.8 
0.2
6 
0.1 - 
0.6 
39.
1 
30.8 - 
48.1 
94.
0 
86.5 - 
97.5 
>128 81.82 59.7 - 
94.8 
70.33 59.8 - 
79.5 
2.7
6 
1.9 - 
4.0 
0.2
6 
0.1 - 
0.6 
40.
0 
31.5 - 
49.2 
94.
1 
86.7 - 
97.5 
>138 81.82 59.7 - 
94.8 
72.53 62.2 - 
81.4 
2.9
8 
2.0 - 
4.4 
0.2
5 
0.1 - 
0.6 
41.
9 
32.8 - 
51.5 
94.
3 
87.1 - 
97.6 
>141 81.82 59.7 - 
94.8 
74.73 64.5 - 
83.3 
3.2
4 
2.2 - 
4.9 
0.2
4 
0.10 
- 0.6 
43.
9 
34.3 - 
54.0 
94.
4 
87.4 - 
97.7 
94 
 
>143 81.82 59.7 - 
94.8 
75.82 65.7 - 
84.2 
3.3
8 
2.2 - 
5.1 
0.2
4 
0.10 
- 0.6 
45.
0 
35.1 - 
55.3 
94.
5 
87.6 - 
97.7 
>147 81.82 59.7 - 
94.8 
76.92 66.9 - 
85.1 
3.5
5 
2.3 - 
5.4 
0.2
4 
0.10 
- 0.6 
46.
2 
35.9 - 
56.7 
94.
6 
87.7 - 
97.7 
>148 81.82 59.7 - 
94.8 
79.12 69.3 - 
86.9 
3.9
2 
2.5 - 
6.1 
0.2
3 
0.09 
- 0.6 
48.
6 
37.8 - 
59.7 
94.
7 
88.1 - 
97.8 
>150 81.82 59.7 - 
94.8 
81.32 71.8 - 
88.7 
4.3
8 
2.7 - 
7.0 
0.2
2 
0.09 
- 0.5 
51.
4 
39.8 - 
62.9 
94.
9 
88.3 - 
97.8 
>159 81.82 59.7 - 
94.8 
82.42 73.0 - 
89.6 
4.6
5 
2.9 - 
7.6 
0.2
2 
0.09 
- 0.5 
52.
9 
40.9 - 
64.7 
94.
9 
88.5 - 
97.9 
>166 77.27 54.6 - 
92.2 
82.42 73.0 - 
89.6 
4.3
9 
2.7 - 
7.2 
0.2
8 
0.1 - 
0.6 
51.
5 
39.2 - 
63.6 
93.
8 
87.3 - 
97.0 
>172 72.73 49.8 - 
89.3 
82.42 73.0 - 
89.6 
4.1
4 
2.5 - 
6.9 
0.3
3 
0.2 - 
0.7 
50.
0 
37.4 - 
62.6 
92.
6 
86.3 - 
96.1 
>175 68.18 45.1 - 
86.1 
82.42 73.0 - 
89.6 
3.8
8 
2.3 - 
6.6 
0.3
9 
0.2 - 
0.7 
48.
4 
35.6 - 
61.4 
91.
5 
85.2 - 
95.2 
>176 68.18 45.1 - 
86.1 
83.52 74.3 - 
90.5 
4.1
4 
2.4 - 
7.1 
0.3
8 
0.2 - 
0.7 
50.
0 
36.7 - 
63.3 
91.
6 
85.4 - 
95.3 
>178 63.64 40.7 - 
82.8 
83.52 74.3 - 
90.5 
3.8
6 
2.2 - 
6.8 
0.4
4 
0.2 - 
0.8 
48.
3 
34.8 - 
62.0 
90.
5 
84.4 - 
94.3 
>179 63.64 40.7 - 
82.8 
84.62 75.5 - 
91.3 
4.1
4 
2.3 - 
7.4 
0.4
3 
0.2 - 
0.8 
50.
0 
36.0 - 
64.0 
90.
6 
84.6 - 
94.4 
95 
 
>180 63.64 40.7 - 
82.8 
85.71 76.8 - 
92.2 
4.4
5 
2.5 - 
8.1 
0.4
2 
0.2 - 
0.7 
51.
9 
37.3 - 
66.1 
90.
7 
84.8 - 
94.5 
>182 63.64 40.7 - 
82.8 
86.81 78.1 - 
93.0 
4.8
3 
2.6 - 
8.9 
0.4
2 
0.2 - 
0.7 
53.
8 
38.7 - 
68.3 
90.
8 
85.0 - 
94.5 
>183 63.64 40.7 - 
82.8 
87.91 79.4 - 
93.8 
5.2
6 
2.8 - 
10.0 
0.4
1 
0.2 - 
0.7 
56.
0 
40.2 - 
70.7 
90.
9 
85.1 - 
94.6 
>185 59.09 36.4 - 
79.3 
89.01 80.7 - 
94.6 
5.3
8 
2.7 - 
10.6 
0.4
6 
0.3 - 
0.8 
56.
5 
39.7 - 
72.0 
90.
0 
84.4 - 
93.7 
>188 59.09 36.4 - 
79.3 
90.11 82.1 - 
95.4 
5.9
7 
2.9 - 
12.2 
0.4
5 
0.3 - 
0.8 
59.
1 
41.5 - 
74.6 
90.
1 
84.6 - 
93.8 
>190 54.55 32.2 - 
75.6 
91.21 83.4 - 
96.1 
6.2
0 
2.9 - 
13.3 
0.5
0 
0.3 - 
0.8 
60.
0 
41.1 - 
76.3 
89.
2 
83.9 - 
92.9 
>201 45.45 24.4 - 
67.8 
93.41 86.2 - 
97.5 
6.8
9 
2.8 - 
16.9 
0.5
8 
0.4 - 
0.9 
62.
5 
40.4 - 
80.4 
87.
6 
82.8 - 
91.2 
>202 40.91 20.7 - 
63.6 
96.70 90.7 - 
99.3 
12.
41 
3.7 - 
42.1 
0.6
1 
0.4 - 
0.9 
75.
0 
46.9 - 
91.0 
87.
1 
82.7 - 
90.6 
>203 9.09 1.1 - 2
9.2 
97.80 92.3 - 
99.7 
4.1
4 
0.6 - 
27.8 
0.9
3 
0.8 - 
1.1 
50.
0 
13.0 - 
87.0 
81.
7 
79.5 - 
83.6 
>229 9.09 1.1 - 2
9.2 
98.90 94.0 - 
100.0 
8.2
7 
0.8 - 
87.2 
0.9
2 
0.8 - 
1.1 
66.
7 
16.0 - 
95.5 
81.
8 
79.7 - 
83.7 
>280 9.09 1.1 - 2
9.2 
100.0
0 
96.0 - 
100.0 
    0.9
1 
0.8 - 
1.0 
10
0.0 
  82.
0 
79.9 - 
83.9 
96 
 
>306 4.55 0.1 - 2
2.8 
100.0
0 
96.0 - 
100.0 
    0.9
5 
0.9 - 
1.0 
10
0.0 
  81.
2 
79.8 - 
82.6 
>336 0.00 0.0 - 1
5.4 
100.0
0 
96.0 - 
100.0 
    1.0
0 
1.0 - 
1.0 
    80.
5 
80.5 - 
80.5 
 
 
 
 
 
 
TABLE 2 
 
  
Case Summary LAPAROSCOPIC PATIENTS ONLY 
 Valid N (listwise) 
LEAK OCCURENCE Unweighted Weighted 
Positive 4 4.00 
Negative 29 29.00 
97 
 
 
 
Area Under the Curve (DAY 4 CRP) 
   Asymp. 95% Confidence Interval 
Area Std. Error Asymptotic Sig. Lower Bound Upper Bound 
.88 .09 .014 .73 1.04 
Coordinates of the Curve (DAY 4 CRP) 
Positive if greater than or equal to Sensitivity 1 - Specificity 
8.69 1.00 1.00 
11.05 1.00 .93 
39.25 1.00 .72 
98 
 
42.40 1.00 .72 
44.70 1.00 .72 
48.55 1.00 .72 
59.85 1.00 .62 
62.90 1.00 .59 
63.60 1.00 .59 
64.85 1.00 .59 
66.25 1.00 .59 
74.15 1.00 .52 
74.95 1.00 .52 
79.75 1.00 .52 
89.95 1.00 .48 
99.35 1.00 .41 
105.50 .75 .41 
106.30 .75 .41 
106.80 .75 .41 
111.70 .75 .38 
119.20 .75 .34 
119.35 .75 .34 
120.45 .75 .31 
134.65 .75 .28 
145.00 .75 .24 
99 
 
147.35 .75 .24 
158.00 .75 .21 
160.50 .75 .21 
164.00 .75 .21 
169.00 .75 .21 
195.00 .75 .10 
202.50 .75 .03 
204.00 .00 .00 
 
